Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Sugammadex Sodium Injection

Approval Number

国药准字H20233991

Company重庆药友制药有限责任公司

Registration Date

August 1, 2023

Drug Information

Generic Name

舒更葡糖钠注射液

Dosage Form

注射剂

Strength

按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计算 2ml:200mg

Drug Type

化学药品

Registration Date

August 1, 2023

Company Information

Applicant Company

Company Name重庆药友制药有限责任公司

Company Address

重庆市渝北区人和镇星光大道100号

Manufacturing Company

Company Name重庆药友制药有限责任公司

Company Address

重庆市渝北区人和镇星光大道100号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

舒更葡糖钠注射液 - NMPA 批准文号 | MedPath